STOLFI, CARMINE
 Distribuzione geografica
Continente #
NA - Nord America 19.627
EU - Europa 1.779
AS - Asia 1.353
SA - Sud America 95
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 22.867
Nazione #
US - Stati Uniti d'America 19.606
SG - Singapore 761
IT - Italia 351
DE - Germania 284
CN - Cina 267
IE - Irlanda 231
UA - Ucraina 230
RU - Federazione Russa 166
HK - Hong Kong 155
SE - Svezia 137
GB - Regno Unito 114
KR - Corea 97
BR - Brasile 85
FR - Francia 78
FI - Finlandia 71
PL - Polonia 35
BE - Belgio 21
ID - Indonesia 20
AT - Austria 17
CA - Canada 14
NL - Olanda 11
IN - India 9
JP - Giappone 7
CZ - Repubblica Ceca 5
ES - Italia 5
LT - Lituania 5
TR - Turchia 5
BD - Bangladesh 4
CL - Cile 4
RO - Romania 4
AR - Argentina 3
DM - Dominica 3
EG - Egitto 3
GR - Grecia 3
IQ - Iraq 3
IR - Iran 3
KZ - Kazakistan 3
MK - Macedonia 3
MX - Messico 3
NO - Norvegia 3
PH - Filippine 3
UZ - Uzbekistan 3
CH - Svizzera 2
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
MA - Marocco 2
PS - Palestinian Territory 2
TN - Tunisia 2
ZA - Sudafrica 2
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
BT - Bhutan 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
VN - Vietnam 1
Totale 22.867
Città #
Woodbridge 5.375
Wilmington 4.827
Houston 4.610
Fairfield 831
Singapore 516
Ann Arbor 477
Chandler 464
Ashburn 406
Seattle 322
Cambridge 291
Jacksonville 212
Dublin 209
Medford 171
Rome 167
Hong Kong 148
Santa Clara 136
Dearborn 130
Beijing 101
New York 95
The Dalles 78
Lawrence 75
San Diego 48
Kraków 34
Zhengzhou 34
Council Bluffs 32
Menlo Park 29
Moscow 29
Mülheim 27
London 24
Brussels 21
Helsinki 19
Jakarta 19
Boardman 17
Seoul 17
Milan 16
Munich 15
Redwood City 15
Hangzhou 14
Mountain View 14
Terzigno 14
Colorado Springs 12
Nuremberg 12
Shanghai 12
Norwalk 11
Palo Alto 11
Toronto 10
Nanjing 9
Kilburn 8
Los Angeles 8
San Mateo 8
Vienna 8
Creede 7
Guangzhou 7
Saint Petersburg 7
Verona 7
North Hollywood 6
Nürnberg 6
University Park 6
Brno 5
Cedarhurst 5
Hanover 5
Naples 5
Nepi 5
North Bergen 5
São Paulo 5
Auburn Hills 4
Bari 4
Chengdu 4
Chicago 4
Del Norte 4
Duncan 4
Falls Church 4
Frankfurt am Main 4
Goiânia 4
Hefei 4
Lappeenranta 4
Nanchang 4
Pune 4
Atlanta 3
Fuzhou 3
Indiana 3
Kunming 3
Lusciano 3
Manila 3
Prescot 3
Rio de Janeiro 3
Roseau 3
Salt Lake City 3
Shenyang 3
Tashkent 3
Tokyo 3
Washington 3
Aarhus 2
Adana 2
Alexandria 2
Amsterdam 2
Belo Horizonte 2
Campinas 2
Center 2
Chennai 2
Totale 20.379
Nome #
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 491
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 486
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 461
A functional role for Smad7 in sustaining colon cancer cell growth and survival 460
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 444
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 442
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 441
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 440
The dual role of Smad7 in the control of cancer growth and metastasis 436
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 436
Regulation of gut inflammation and Th17 cell response by interleukin-21 435
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 433
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 431
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 430
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 430
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 428
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 427
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 423
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 423
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 422
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 422
Colorectal cancer chemoprevention by mesalazine and its derivatives 417
Autocrine regulation of IL-21 production in human T lymphocytes 415
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 407
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 405
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 405
Collagen matrix injection combined with flap repair for complex anal fistula 403
The dual role of inflammation in colon carcinogenesis 401
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 400
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 397
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 395
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 393
Role of TH17 cytokines in the control of colorectal cancer 387
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 387
Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery. 387
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 378
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer 369
Molecular basis of the potential of mesalazine to prevent colorectal cancer 367
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 366
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis 360
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression 359
Smad7 positively regulates keratinocyte proliferation in psoriasis 339
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease 337
IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis 326
Interleukin-21 in cancer immunotherapy: Friend or foe? 317
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 316
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 301
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death 296
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 284
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 284
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 202
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide 194
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells 178
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 169
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 169
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells 145
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 142
Molecular targets of mesalazine in colorectal cancer 135
{STAT}3 Interactors as Potential Therapeutic Targets for Cancer Treatment 127
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 104
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 98
Follistatin-like protein 1 sustains colon cancer cell growth and survival 93
NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals 91
Repositioning of anthelmintic drugs for the treatment of cancers of the digestive system 90
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 90
Association between celiac disease and cancer 84
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis 78
Aptamer linked to DNA nanostructures diverts its traffic inside cancer cells and improves its therapeutic efficacy 73
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 69
Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures 68
Role of interleukin-34 in cancer 62
RORγt-Expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells 62
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis 59
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 57
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 50
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases 49
The AtMYB11 gene from Arabidopsis is expressed in meristematic cells and modulates growth in planta and organogenesis in vitro 45
null 44
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells 44
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 40
Impact of food additives on gut homeostasis 32
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 31
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut† 30
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells 29
Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials 29
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 26
TRAIL-Sensitizing Effects of Flavonoids in Cancer 23
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 23
Anthelmintic Drugs as Emerging Immune Modulators in Cancer 22
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 22
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 21
null 20
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders? 19
null 18
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue “State-of-the-Art Molecular Oncology in Italy” 17
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance 17
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut 17
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response 16
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier 16
The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis 15
Totale 23.193
Categoria #
all - tutte 55.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.186 0 0 0 0 0 0 0 0 0 461 326 399
2020/20214.039 314 390 852 460 341 441 427 363 91 176 122 62
2021/2022870 45 97 57 19 28 61 59 28 90 76 70 240
2022/20231.154 101 107 32 140 120 221 95 94 111 39 69 25
2023/2024458 54 18 26 17 46 118 21 84 4 4 2 64
2024/20252.037 76 562 322 190 57 220 157 99 277 77 0 0
Totale 23.289